Marrone Bio Innovations, Inc. (MBII) Financial Statements (2024 and earlier)

Company Profile

Business Address 7780-420 BRIER CREEK PARKWAY
RALEIGH, NC 27617
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 287 - Agricultural Chemicals (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2022
MRQ
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 19,62315,8416,25218,2217869,609
Cash and cash equivalents 19,62315,8416,25218,2217869,609
Restricted cash and investments     4871,444
Receivables 13,211 5,9252,7203,7853,592
Inventory, net of allowances, customer advances and progress billings 8,6336,6188,1498,2249,8278,482
Inventory 8,6336,6188,1498,2249,8278,482
Other undisclosed current assets 1,21111,8011,3909714,2333,748
Total current assets: 42,67834,26021,71630,13619,11826,875
Noncurrent Assets
Operating lease, right-of-use asset 3,6373,7604,567
Property, plant and equipment 12,67612,56513,26014,51216,01617,343
Intangible assets, net (including goodwill) 25,75128,12330,606   
Goodwill 6,7406,7406,764   
Intangible assets, net (excluding goodwill) 19,01121,38323,842   
Restricted cash and investments 1,5601,5601,5601,5601,5601,560
Other noncurrent assets 7549291,008359219205
Total noncurrent assets: 44,37846,93751,00116,43117,79519,108
TOTAL ASSETS: 87,05681,19772,71746,56736,91345,983
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 21,46013,54515,8468,56311,9896,893
Employee-related liabilities 3,922     
Accounts payable 2,6871,8953,3791,6923,8001,385
Accrued liabilities 14,85111,65012,4676,8718,1895,508
Deferred revenue 360374427
Debt 25,9099,3013,8992,3181,5241,091
Deferred revenue and credits6,1935,647
Other undisclosed current liabilities (2,541)1,0089134382,2961,618
Total current liabilities: 45,18824,22821,08511,31922,00215,249
Noncurrent Liabilities
Long-term debt and lease obligation 10,20214,52915,81711,81924,40721,083
Long-term debt, excluding current maturities 7,69111,47911,84711,81924,40721,083
Liabilities, other than long-term debt 2,01311,03012,2578,09441,15539,835
Deferred revenue and credits2,0461,787
Deferred revenue 1,1651,6281,986
Due to related parties  7,3007,3007,30037,82236,667
Other liabilities 8482,1022,9717941,2871,381
Operating lease, liability 2,5113,0503,970
Other undisclosed noncurrent liabilities    2,399  
Total noncurrent liabilities: 12,21525,55928,07422,31265,56260,918
Total liabilities: 57,40349,78749,15933,63187,56476,167
Equity
Equity, attributable to parent 29,65331,41023,55812,936(50,651)(30,184)
Common stock 1111  
Additional paid in capital 387,023372,226344,206296,409214,921204,463
Accumulated deficit (357,371)(340,817)(320,649)(283,474)(265,572)(234,647)
Total equity: 29,65331,41023,55812,936(50,651)(30,184)
TOTAL LIABILITIES AND EQUITY: 87,05681,19772,71746,56736,91345,983

Income Statement (P&L) ($ in thousands)

3/31/2022
TTM
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Revenues 44,31038,37429,37321,22018,16714,042
Revenue, net18,16714,042
Cost of revenue (17,064)(15,505)(13,260)(10,907)(10,528)(9,522)
Gross profit: 27,24622,86916,11310,3137,6394,520
Operating expenses (42,650)(40,064)(44,098)(29,817)(30,634)(28,180)
Operating loss: (15,404)(17,195)(27,985)(19,504)(22,995)(23,660)
Nonoperating expense (1,105)(2,944)(9,190)(709)(7,930)(7,411)
Other nonoperating income (expense) (174)407255(11)(106)(146)
Interest and debt expense (1,570)(1,443)(1,474)(2,196)(3,374)(2,941)
Other undisclosed income from continuing operations before equity method investments, income taxes  1,4431,474   
Loss from continuing operations before equity method investments, income taxes: (18,079)(20,139)(37,175)(22,409)(34,299)(34,012)
Other undisclosed income from continuing operations before income taxes 1,570   3,3742,941
Loss from continuing operations before income taxes: (16,509)(20,139)(37,175)(22,409)(30,925)(31,071)
Income tax expense (45)(29)(28)   
Loss from continuing operations: (16,554)(20,168)(37,203)(22,409)(30,925)(31,071)
Loss before gain (loss) on sale of properties:(16,554)(20,168)(37,203)(22,409)(30,925)(31,071)
Net loss: (16,554)(20,168)(37,203)(22,409)(30,925)(31,071)
Other undisclosed net income attributable to parent   282,196  
Net loss available to common stockholders, diluted: (16,554)(20,168)(37,175)(20,213)(30,925)(31,071)

Comprehensive Income ($ in thousands)

3/31/2022
TTM
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Net loss: (16,554)(20,168)(37,203)(22,409)(30,925)(31,071)
Comprehensive loss, net of tax, attributable to parent: (16,554)(20,168)(37,203)(22,409)(30,925)(31,071)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: